- Latest available (Revised)
- Point in Time (24/05/2018)
- Original (As made)
Point in time view as at 24/05/2018.
There are currently no known outstanding effects for the The Pharmacy (Premises Standards, Information Obligations, etc.) Order 2016, Section 19.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
19.—(1) Article 7 of the 2010 Order (standards: general) is amended as follows.
(2) For paragraph (1) substitute—
“(1) In the exercise of its functions under article 4(3)(b), the Council must set standards that are to be met in connection with the carrying on of a retail pharmacy business at or from a registered pharmacy by the person carrying on that business.”.
(3) Omit paragraph (2).
(4) For paragraph (3) substitute—
“(3) The standards may, in particular, relate to—
(a)governance arrangements for registered pharmacies, including arrangements for managing and monitoring the safe and effective provision of pharmacy services at or from registered pharmacies;
(b)the working environment at and the condition of registered pharmacies;
(c)the patient and public experience of pharmacy services provided at or from registered pharmacies;
(d)the condition of the equipment and facilities used in the provision of pharmacy services at or from registered pharmacies;
(e)the working environment at and condition of associated premises and the condition of equipment and facilities at associated premises (being premises at which activities are carried on which are integral to the provision of pharmacy services at or from registered pharmacies), but only to the extent appropriate for ensuring the safe and effective provision of pharmacy services at or from registered pharmacies;
(f)training of staff of the retail pharmacy business;
(g)arrangements for ensuring staff of the retail pharmacy business—
(i)have the authority and ability to act to ensure, and
(ii)are properly held accountable for,
the health, safety and well-being of patients to whom pharmacy services are provided at or from registered pharmacies, and of other persons at registered pharmacies.”.
(5) In paragraph (4)—
(a)for “must also” substitute “may”; and
(b)in sub-paragraph (b)—
(i)omit “or” at the end of paragraph (i),
(ii)after paragraph (i) insert the following paragraph—
“(ia)on or within a specified period after the occurrence of any event (which includes a decision that an event is to occur) of a description specified in the rules, or”, and
(iii)for paragraph (ii) substitute the following paragraph—
“(ii)on such dates or at such intervals as may be specified in the rules or the Council may determine (whether generally, in relation to a description of persons carrying on a retail pharmacy business or in relation to particular persons carrying on such a business); and”.
(6) In paragraph (5)—
(a)for “must,” substitute “may,”; and
(b)for sub-paragraph (c), substitute—
“(c)where medicinal products are sold by retail, or supplied in circumstances corresponding to retail sale, at or from premises of a body corporate that is carrying on a retail pharmacy business at or from those premises, the name and home address of the superintendent pharmacist of that business;”.
(7) In paragraph (6)—
(a)in sub-paragraph (a)—
(i)in paragraph (i), after “charged” insert “or for which that individual has been cautioned”,
(ii)in paragraph (ii), for “has been charged” substitute “or the partnership (whether or not as an entity separate from the partners) has been charged or for which the partner or partnership has been cautioned”, and
(iii)in paragraph (iii), for “has been charged” substitute “or (if not a director) its superintendent pharmacist has been charged or for which the body corporate, a director or the superintendent pharmacist has been cautioned”; and
(b)in sub-paragraph (b)—
(i)in paragraph (ii), after “a partnership,” insert “the partnership or”, and
(ii)in paragraph (iii), after “any director” insert “or (if not a director) the superintendent pharmacist”.
(8) Omit paragraph (7).
Commencement Information
I1Art. 19 not in force at made date, see art. 1(3)
I2Art. 19 in force at 24.5.2018 by S.I. 2018/512, art. 2(1)(b)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: